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1. Introduction 
The Wnt signaling pathway is a key regulator of developmental and homeostatic processes, 
including embryogenesis, stem cell maintenance, cell fate specification, cell polarity, 
migration, and, when is aberrantly activated, cancer progression. The Wnt pathway is a 
highly conserved mechanism during evolution, hence homologues of this via can be found 
in metazoan organisms, showing a crucial role in the developmental processes of metazoan 
body (Pang et al., 2010). 
The aim of the current chapter is to review and analyze recent data pointing to specific 
alterations in Wnt pathway components occurring during Cervical Cancer (CC) progression. 
We address an overall discussion about the feasible role of E6/E7 proteins as chromatin 
remodelers, hence turning off by promoter silencing or turning on, by recruiting co-
activators and transcription factors to genes that promote malignant progression. We also 
present our results, highlighting Wnt aberrant activation in cervical biopsies. Therefore, we 
propose that cervical neoplasms caused by high-risk human papillomavirus (HPV) activate 
the Wnt/beta-catenin pathway in order to establish and progress.  
2. HPV viral cycle and cervical cancer development 
Epidemiological and molecular studies have shown a causal relationship between high-risk 
HPV infection and CC development (Walboomers et al., 1999). However, HPV is a necessary 
agent, but not sufficient cause of cervical intraepithelial neoplasia and CC. The above 
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mentioned arises from epidemiological studies that demonstrated that HPV is one of the 
most common sexually transmitted agents with prevalence between 10-40 percent in women 
who have no cytological abnormalities (Jacobs et al., 2000; Molano et al., 2002). There is 
enough evidence suggesting that is very likely that most of people could have an HPV sub-
clinical infection, especially increasing the risk at juvenile ages (younger than 25 years old). 
This is due to many factors, for instance, in the case of older women could be the acquired 
immunity to HPV from previous exposures, likewise the alcohol consumption and the 
number of sexual partners can increase specific risk (Burk et al., 1996;  Kjaer et al., 1997;  Ho 
et al., 1998;  Lazcano-Ponce et al., 2001.). 
Moreover, other cohort and multi-center studies have shown that the presence of the viral 
sequence can reach up to 85% in women who have no cytological abnormalities detected by 
pap-smear (Roteli-Martins et al., 2011). Apparently the median duration of HPV infection is 
around eight months with a high consistence between different populations (Ho et al., 1998; 
Franco et al., 1999.; Molano et al., 2002.). Thus, we can conclude that in the CC multistep 
carcinogenesis process HPV persistent infection is the initial step, however, other factors are 
involved towards the development of malignant phenotype.  
Regarding HPV molecular events towards carcinogenesis, there are three key events during 
HPV course of infection associated with cancer: 1) viral DNA integration to host genome; 2) 
expression of viral proteins (namely E1, E2, E4, E5, E6 and E7), and 3) the complex 
interactions between E2, E6/E7 and cellular proteins (Figure 1). Cervical cancer is a complex 
disease elicited by the interaction of viral, host, and environmental factors, exerting an 
influence on the risk of disease progression from early cervical abnormalities to invasive 
cancer; thus the proper identification of involved factors will lead us to a better knowledge 
of the natural history of HPV infection.  
Once HPV has infected basal cells, the viral genome is actively replicated as episome and early 
genes (E1–E7) are expressed. E1 and E2 are essential proteins for viral genome replication and 
viral cycle completion (Matsukura et al., 1989). E1 is an ATP-dependent DNA helicase which 
unwinds the double-stranded viral DNA and interacts with the -primase subunit of the DNA 
polymerase, to recruit the replication complex to the viral replication origin (Masterson et al., 
1998; Conger et al., 1999). E1 also interacts with multiple cyclins and is phosphorylated by 
cyclin/CDK complexes (Dalton et al., 1995; Cueille et al., 1998.). These interactions require the 
consensus RxL cyclin binding motif, present in the amino-terminal domain of the E1 protein. 
Moreover, mutation of RxL motif severely compromises replication of viral genome (Ma et al., 
1999), suggesting that E1 is regulating HPV genome replication through interaction with 
cyclins and CDKs complexes (Deng et al., 2004).  
The full-lenght E2 protein is a sequence-specific transcription factor that functions as an 
activator or repressor to tightly regulate the transcriptional activity of all HPV genes. This is 
achieved through four consensus E2-binding sites (E2-BSs), ACCGN4CGGT, whose 
locations within the upstream regulatory region (URR) are highly conserved among genital 
HPVs (Fig. 1; Hedge, 2002; Hou et al., 2002). It has also been seen that E2 participates in viral 
DNA replication via interaction with the protein E1 (Chiang et al., 1992). Hence, the versatile 
role of E2 protein functioning as a transcriptional repressor/activator and promoting 
genome DNA replication could be explained by E2-BSs occupancy in a context-dependent 
fashion. In this respect, E2 binding to E2-BS4 can especifically up-regulate viral early gene 
expression, including the expression of oncogenes E6 and E7. In contrast, E2 binding at the 
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promoter-proximal sites E2-BS1 and E2-BS2 leads to transcriptional repression of the early 
genes, including E6 and E7, whereas the E2-BS3 site is important for viral DNA replication 
(Steger & Corbach, 1997; Stubenrauch & Pfister, 1994; Stubenrauch et al., 1998). In this way, 
E2 contributes to the cell cycle control by regulating the expression of E6 and E7. Repression 
of HPV-early genes mediated by E2 appears to involve the displacement of cellular 
transcription factors from the viral promoter (Tan et al., 1994). Therefore, viral DNA 
replication and viral gene expression reflect the relative occupancy of different E2 binding 
sites, finely modulated by the concentration of the E2 protein (Figure 2A). 
 
Fig. 1. HPV viral cycle and cervical cancer development.  
Human papillomavirus infect epithelial basal cells through mechanical microabrassions or by 
infecting the transformation zone, an abrupt transition from a columnar to a squamous 
epithelium (Phase 1). Infected cells actively express the early genes E1, E2, E4 and E5 (Phase 2). 
E6 and E7 are expressed in limited amounts due to transcriptional modulation exert by E2, 
which permits to cells have a higher cell cycle rate. Infected basal cells migrate to the lumen as 
they differentiate expressing the late capside genes L1 and L2 (Phase 3). Viral genome is 
replicated as an episome in sub-clinical infections or low grade intra-epithelial-lesions (LGSIL), 
and is encapsidated in the nucleus of the upper layer epithelium (Phase 4). Shed viral particles 
then can infect new zones of epithelium or be sexually transmitted. Only a limited number of 
infections progress to high grade intra-epithelial-lesions (HGSIL) and cervical carcinoma (CC). 
The progression of LGSIL to CC is associated with the integration of the HPV genome into the 
host genome and the loss of transcriptional repression exerted by E2. 
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However, E2 is not only a transcription factor, but can also induce apoptosis in absence of 
any other HPV open reading frame by its association to the DED motif of caspase-8. HPV-18 
E2 protein induces caspase oligomerization through its amino-terminus motif containing a 
27 amino-acid -helix (Demeret et al., 2003; Thierry & Demeret C., 2008). In this context, HPV-
16 E2 protein induces apoptosis by means of the binding to p53; this interaction has 
important implications in the viral cycle. Fo example, it has been reported elsewhere that 
p53-E2 heterodimer can down-regulate HPV-16 DNA replication (Webster et al., 2000; 
Brown et al., 2008). It is known that E2 regulates the cell cycle progression through two main 
mechanisms: a) by means of apoptosis either p53-dependent or caspase induction pathway; 
and by b) balancing the expression/repression of oncoviral proteins E6 an E7. That balance 
executed by E2 is broken upon HPV integration onto the host genome.  
HPV genome replicates as episome or extrachromosomic molecule in benign cervical 
precursor lesions. However, cancer tissues can contain both episomal and integrated HPV 
DNA that has been covalently incorporated into the host cell chromosomal DNA (Cullen et al., 
1991; Hudelist et al., 2008). Because the HPV genome is a ring molecule, it requires to be open 
in order to be integrated; this process involves a breakage in the E1–E2 open reading frames 
region and deletion of E2 and adjacent regions E2–E4, E5, and L2, after integration. Hence, as 
we discussed above the fine tune on the expression levels of E6 and E7 exerted by E2 is lost 
and viral oncogenes E6 and E7 are actively expressed in CC tissue (Ueda et al., 2003). It has 
been suggested that common sites of viral integration are cellular genes that could contribute 
essentially to the enhanced progression risk of HPV-induced premalignant lesions to 
neoplastic lesions. Thus, it has been reported that frequent integration sites are near to MYC, 
NR4A2, hTERT, APM-1, FANCC, and TNFAIP2 (reviewed by Wentzensen et al., 2004).  
2.1 Effect of protein-protein interactions of E6 and E7 with nuclear proteins in the 
regulation of transcription 
The active expression of E6 and E7 is required to increase the proliferation capacity of 
malignant cells and uncoupling differentiation through targeting prominent regulators of 
cell cycle control progression. E6 and E7 epithelial expression and its interactions with 
cellular proteins have been at the center of the HPV biomedical research scenario probably 
for the past 20 years. The central core of the classic E6/E7 model is the binding and 
inactivation of tumour suppressor proteins p53 and pRb, respectively; which was 
established between the late 1980’s and the early 1990’s (Dyson et al., 1989; Scheffner et al., 
1990). Currently, it is well-known that E6 and E7 interact with a plethora of cellular proteins, 
in the nucleus and in the cytoplasm, that participate in molecular pathways involved in the 
activation and establishment of the malignant phenotype. We will not discuss about the 
cytoplasmic interactions between E6/E7 with cellular proteins but there are some available 
reviews previously published that are highly recommended, with extensive and 
comprehensive content (Moody & Laimins, 2010; Lavia et al., 2003). 
It has been well described that E6 and E7 do not posses DNA-binding domains (Mallon et 
al., 1987; Grossman et al., 1988). However, in the nucleus these viral products interact with 
chromatin remodeling proteins, such as the histone acetyl transferase CREB-binding protein 
CBP/P300; with transcriptional coactivators, such as hADA3; with transcription factors, 
such as AP1, IRF3, E2F1, TBP, MPP2, SRC-1 and pCAF; DNA-methyl transferases, and the 
telomerase (Antinore et al., 1996;  Phillips & Vousden, 1997; Ronco et al., 1998; Lüscher-
Firzlaff et al., 1999;  Huang & McCance, 2002;  Hwang et al., 2002; Maldonado et al., 2002; 
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Baldwin et al., 2006; ; Burgers et al., 2007; Liu et al., 2009.). These protein-protein interactions 
may conduct important changes in transcriptional regulation by the direct action of these 
viral oncoproteins upon specific genes. For instance, E6 and E7 recruit c-Jun, c-Fos and 
CBP/p300, and also inhibit the binding of the repressive histone deacetylase NCoR to the 
promoter of COX-2. This corepressor/coactivator exchange caused by E6 and E7 induce the 
expression of this target gene (Subbaramaiah and Dannenberg, 2007; Haertel-Wiesmann et 
al., 2000; Howe et al., 1999). In addition, the over-expression of COX-2 could accentuate the 
malignant phenotype induced by Wnt hyper-activation and correlates with the progression 
of cervical epithelial lesions and lymph node metastasis in cervical cancer patients (Liu et al., 
2011; Balan et al., 2011). Likewise, the interaction between E6 and E7 with CBP/p300 has 
been described in the context of the promoters of TP53 and the proinflammatory IL-8. This 
event inhibits the histone acetylation of TP53 promoter region and prevents the interaction 
between CBP/p300 with NFkappa-B and SRC-1 in the promoter of IL-8, which results in the 
inhibition of the expression of p53 and IL-8 (Bernat et al., 2003). Altogether, this aberrant 
repression contributes to hinder apoptosis, induce malignant transformation and could 
compromise the immune response against HPV. Aditionally, the E6-hADA3 interaction 
prevents the transactivation of TP53 and the transcriptional induction mediated by the 
retinoic X receptor (Hu et al,. 2009; Zeng et al., 2002, Kumar et al., 2002). Moreover, the 
binding between E7 and DNMT1 stimulate the methyltransferase activity of this enzyme, 
producing an aberrant hypermethylation state, which could lead to the silencing of tumour 
suppressor genes and cellular transformation (Burgers et al., 2007). Similarly, the promoter 
of the catalytic subunit of hTERT has E6 and cellular transcription factor Myc consensus 
sequences both actively participating in the induction of this gene (Sekaric et al., 2008). This 
effect is consistent with the increased hTERT activity observed in primary epithelial cells 
transfected with E6 and provides a molecular basis for the immortalization of these cells 
(Klingelhutz et al., 1996). Furthermore, E6 can interact directly with hTERT, this interaction 
upregulates the activity of hTERT which could be determinant for cellular immortalization 
and progression to cancer (Liu et al., 2009). 
As we have described above, E2 has a functional DNA-binding domain and regulates viral 
gene expression. In addition, E2 can also regulate the expression of relevant cellular genes. 
In this regard, E2 binds to and transactivates the promoter of the splicing factor SF2/ASF. 
SF2/ASF participates in the regulation of the alternative splicing, and its overexpression 
mediated by E2 could be related to the production of the viral alternative transcripts of L1 
and L2 in the replicative cycle (Mole et al., 2009). E2 also interacts with the transcription 
factor Sp1 in the promoter of hTERT to repress its expression (Lee et al., 2002). This fact is 
consistent with the increased hTERT transcription observed in cells that have lost E2 as a 
result of viral genome integration, and is independent of E6 co-activation of the hTERT 
promoter (Lee et al., 2002; Sekaric et al., 2008). Additionaly, E2 can interact with C/EBP to 
promote keratinocyte differentiation (Hadaschick et al., 2003). Altogether, these findings 
illustrate mechanisms that participate in differentiation, growth inhibition and senescence 
induction, which are associated to E2 function (Dowhanick et al., 1995). 
These findings reveal that the interaction of E6, E7 and E2 with nuclear proteins could 
constitute a hallmark of transcriptional regulation. This direct trans regulation exerted by 
the presence in situ of these viral proteins in human promoters, in the form of co-regulatory 
complexes (E6 and E7) or by direct binding to DNA (E2), could occur at a global, genomic 
level. These events provide new molecular mechanisms of aberrant phenotype 
development, where E2 and E6/E7 have counteracting forces. Therefore, the new horizon in 
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the comprehension of the molecular pathology of HPV must address this complex nuclear 
scenario, in which cellular and viral proteins are partners in the promotion of the malignant 
phenotype (Figure 2B).   
 
 
Fig 2. Molecular mechanisms induced by HPV early-expressed proteins. 
A. Meanwhile HPV is maintained as episome, E1 and E2 are actively expressed, which are 
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essential proteins for viral genome replication and viral cycle completion. E2 is a sequence-
specific transcription factor which regulates the E6 and E7 rate of expression; depending on 
E2-BSs occupancy sites. 
B. Human papilloma virus E6 and E7 interact with nuclear proteins such as transcription 
factors, chromatin remodelers, co-activators and DNA methyl-transferases to influence gene 
expression and cellular processes towards malignant phenotype and tumoral progression. 
In the late stage of the infection E2 expression is reduced with a concomitant increase in 
hTERT expression and reduction of differentiation, therefore the oncogenic activity of E6 
and E7 are up-regulated (for details see text). 
3. Wnt cell signalling pathway 
One of the most relevant signaling pathways in tumourigenesis that has been proposed as a 
hallmark of CC initiation and progression is the Wnt/beta catenin pathway (Uren et al., 
2005; Kloth, 2005; Pérez-Plasencia et al., 2007; Pérez-Plasencia et al., 2008). The proto-
oncogenic effects of Wnt were discovered almost 30 years ago in C3H mice bearing 
mammary tumours induced by a viral agent, the mouse mammary tumour virus (MMTV), 
which genomic sequences were integrated in the host genome. After this seminal work it 
was clear that common sites of MMTV integration were int- called sequences, which were 
transcriptionally activated in C3H mice breast tumours and inactivated in their normal 
counterparts (Nusse et al., 1984). Since then, a wealth of evidence has put in the scene the 
significance of Wnt activation during neoplasm progression in a vast majority of tumour 
types. The activity of Wnt proteins encompass the regulation of three pathways: 1) the 
planar cell polarity (PCP) pathway, which controls the polarization and differentiation of 
cells within a plane of an epithelium and is essential in the neural tube closure and 
alignment of the neurosensory hair cells of the cochlea (Curtin et al., 2003;  Quian et al., 
2007.); 2) the Wnt/Ca+2 pathway that regulates cell movement and adhesion (Kuhl et al., 
2000); and 3) the Wnt/beta-catenin or “canonical” pathway, which we will further discuss in 
this chapter, and that is involved in the regulation of proliferation and that is considered as 
a hallmark of cancer as well (Ying & Tao, 2009; Hu & Li, 2010; Morris et al., 2010.).  
Wnt glycoproteins are extracellular ligands found in many species, ranging from the 
ctenophore Mnemiopsis leidyi to humans (Pang et al., 2010). In mammals, Wnt signalling 
regulates the establishment of the anterior-posterior (A-P) axis, which was demonstrated by 
gene depletion in mouse (Zeng et al., 1997). In the adult body, Wnts are involved in the 
regulation of several biological processes, for instance, cell fate specification, proliferation, 
migration, cell adhesion, cell polarity, tissue architecture, organogenesis, and angiogenesis, 
among other. (Wodarz et al., 1988; Peifer et al., 2000;  Ross et al., 2000; Gong et al., 2001; 
Goodwin et al., 2002.). 
In tumours, the Wnt/beta-catenin pathway is activated and regulates the expression of genes 
involved in cell cycle progression, such as cyclin D1 (Tetsu & McCormick, 1999); transcription 
factors, such as cMyc, that enhance the shift to aberrant tumoural metabolism towards aerobic 
glycolisis (He et al., 1998); antiapoptotic proteins, such as survivin (Zhang et al., 2001a); 
proangiogenic factors including VEGF (Zhang et al., 2001b); and metalloproteinases related to 
tumour progression, invasion and metastasis (Brabletz et al., 1999; Crawford et al., 1999). The 
alterations in Wnt canonical pathway have been well characterized in colorectal cancer, in 
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which the via is activated in 80% of cases due to a high rate of mutations in the negative 
regulators, including axin, APC and GSKb1 and activating mutations on -catenin (Miyoshi et 
al., 1992; Bienz & Clevers, 2000; Segditsas & Tomlinson, 2009)(Figure 3).  
 
Fig. 3. Wnt canonical signaling pathway.  
A. WNT Pathway not active. 
When the wnt signaling pathway is not active, β-catenin binds to the degradation complex 
composed by APC, axin, and the serine/theronine kinases CK1 and GSK3. The main role of 
the degradation complex is to phosphorylate β-catenin leading to its degradation by means 
of the proteasome-ubiquitin pathway. βTrCp1 functions as an ubiquiting-ligase protein. The 
pathway can be regulated by several proteins that operate at the receptor-ligand level; such 
as, Cer1, DKK, WIF1 and sFRP, whose function is to modulate positive signals induced by 
Wnts. Planar Cell Polarity pathway (PCP) is regulated by NKD genes which interacts to 
DVL and degrade it by ubiquitination. 
B. WNT Pathway activated.  
The contact of wnt with its receptors leads to the stabilization of β-catenin and its 
accumulation in cytoplasm and nucleus. β-catenin displaces the transcriptional repressor 
groucho from the LEF/TCF complex, leading to the activation of target genes, such as c-myc 
and cyclinD1, which are involved in cell proliferation and cell cycle progression.  
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Wnt binds to and activate the seven-transmembrane domain specific receptors denominated 
Frizzled (FZD). The secretion and post-translational modification of Wnt proteins are 
attained by accompaning molecules, such as porcupine and Wntless (WIs), a process needed 
to the optimal release and Wnt binding to their receptors and co-receptors (reviewed at 
Coudreuse & Korswagen, 2007). The broad range of cellular processes regulated by the Wnt 
pathway can be explained -at least in part- by the high diversity between Wnt proteins and 
FZD receptors: nineteen members of Wnt family and ten FZD genes have been identified in 
higher vertebrates (Wordaz & Nusse R, 1988). Besides, interactions between Wnt proteins 
and their receptors show an important rate of promiscuity (Bahnot et al., 1996). The 
interaction between Wnt and Fzd requires the cooperation of LRP-5/6 co-receptors, which 
are long single-pass transmembrane proteins (Wehrli et al., 2000). In this light, mutational 
studies have shown that both genes are involved in developmental processes; for instance, 
dorsal thalamic development, skeletal and neural tube abnormalities, decrease in osteoblast 
proliferation, osteopenia, and persistent embryonic eye vascularization (Kokubu et al., 2004; 
Zhou et al., 2004; Lindvall, 2006.).  
Another level of regulation operating on the interaction between LRP5/6, FZDs, and Wnts is 
achieved by secreted proteins acting as antagonists such as the secreted frizzled-related 
protein (sFRP), Dickkopf (Dkk), Cerberus1 (Cer1), and KLOTHO, which can inhibit Wnt 
signaling through direct binding to Wnt or co-receptor molecules. Dkk binds to LDL 
receptor-related protein (LRP) with other transmembrane proteins, the Kremens (Krm); thus 
promoting LRP internalization and inactivation (Mao et al., 2002; Pinson et al., 2000). It has 
been observed that the lack of expression of the sFRP1 is common in cervical, breast, ovary 
and kidney neoplasms, by mechanisms that include the loss of the sFRP1 locus in 
chromosome 8p21 and promoter hipermethylation; moreover, sFRP1 downregulation is 
associtated with tumour progression and invasion (Klopocki et al., 2004; Ko et al., 2002; 
Ugolini et al., 2001). Similarly, in primary colorectal carcinomas it has been detected a high 
frequency of hypermethylation on sFRP1, sFRP2, sFRP4 and sFRP5 promoters, which 
correlates to a reduced expression of these genes (Suzuki et al., 2002). In addition, in vitro 
experiments showed that Dkk-3 has reduced expression in immortalized and tumour cells 
and it is frequently downregulated in non-smal cell lung cancer (Tsuji et al., 2000). 
After Wnt binds to their receptor co-receptor complex, FZD recruits Disheveled (Dvl), which 
transduces the Wnt signal into the cell through interaction with several pathway 
components. Indeed, Dvl has a key role in the Wnt signal routing and amplification through 
pathway-specific effectors, by its interaction with axin, which performs a scaffolding 
function in the Wnt pathway by its association with key proteins for β-catenin 
phosphorylation and poly-ubiquitination, including GSK-3β, CK1, APC, and β-catenin itself 
(Zeng et al., 2005; Davidson et al., 2005; McDonald et al., 2009). The consequence of axin 
phosphorylation is inactivation of “degradation complex” and the subsequent activation of 
β-catenin (Xing et al., 2003). Degradation complex is a multi-protein assembly activated in 
the absence of Wnt signaling, whose main task is to add ubiquitins to β-catenin resulting in 
its inactivation by means of the ubiquitin-proteasome pathway (Peifer & Polakis, 2000). A 
key component of the degradation complex is APC. When β-catenin binds to APC, it 
displaces the bound to axin because the binding affinity of β-catenin increases dramatically 
upon phosphorylation and because the binding motifs of APC to axin and β-catenin overlap. 
Most colorectal tumours contain truncating mutations on APC, which leads to an inability to 
bind Axin or degrade β-catenin (Kinzler & Vogelstein, 1996; Xing et al., 2003). 
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Finally, stabilized non-phosphorylated β-catenin tends to accumulate in the cytoplasm 
leading to its nuclear translocation, where it is associated with lymphoid enhancer-binding 
factor 1/Tcell-specific transcription factor (LEF/TCF) and transcriptional activator Pygopus 
(Pygo). Pygo contains a PHD domain, which is shared by many nuclear proteins with a role 
in chromatin remodeling and transcriptional co-activation (Belenkaya et al., 2002). Several 
genes activated by the Wnt signaling pathway, which are involved in cell proliferation and 
differentiation processes have been identified (Daniels & Weis, 2005) (Figure 3).  
The Naked cuticle (Nkd) protein family (NKD1,2), whose activity is required to restrict Wnt 
signaling during Drosophila embryonic segmentation, thus establishing a negative-feedback 
loop and ameliorating canonical Wnt signaling by binding and destabilizing Dsh/Dvl 
proteins (Rousset et al., 2001). NKD was the first Wnt antagonist found to be induced by the 
Wnt pathway (Zeng et al., 2000). Besides, Naked cuticle is proposed to function as a switch, 
acting to restrict classical Wnt signaling and to activate a second Wnt signaling pathway that 
controls planar cell polarity (PCP) during gastrulation movements in vertebrates (Wharton 
et al., 2001). Recently, it has been shown mutations in NKD1 in a subset of DNA mismatch 
repair-deficient colorectal tumours that are not known to harbor mutations in other Wnt-
pathway genes. The mutant Nkd1 proteins were defective at inhibiting Wnt signaling; in 
addition, the mutant Nkd1 proteins stabilize β-catenin and promote cell proliferation, in 
part due to a reduced ability of each mutant Nkd1 protein to bind and destabilize Dvl 
proteins (Guo et al., 2009). Those results suggest that NKD1 is a negative regulator of Wnt 
and an important target of mutations during the carcinogenesis process. 
3.1 Wnt pathway and Cervical Carcinoma 
Wnt/-catenin pathway activation is an established hallmark of cancer; hence, mutations in 
distinct components of this pathway have been studied and identified in nearly all human 
cancers. In contrast to what is observed in other tumours, Wnt canonical pathway activation 
caused by mutations is meaningless in CC. In this regard, cervical high grade lesions have 
an increased expression and nuclear localization of β-catenin with no mutations of CTNNB1 
nor Axin (Shinohara et al., 2001; Pereira-Suárez et al., 2002; Su et al., 2003). Thus, in CC it is 
possible that activation of β-catenin occurs independently of activating mutations by an 
upstream level mechanism, which could be accomplished by the inactivation of negative 
regulators. It is well-known that during carcinogenesis aberrant CpG island methylation 
inactivates distinct tumour suppressor genes, a mechanism that could be explained by 
means of an increase in DNA methyltransferase (DNMT) activity (Robertson, 2001). In this 
context HPV16/E7 has the capacity to bind and increase the DNMT1 activity, (Burgers et al., 
2007); thus, it is feasible that negative Wnt/β catenin-pathway regulators are inactivated by 
methylation. In this respect, sFRPs, axin, DICKKOPF (Dkk), KLOTHO and APC genes have 
enriched CpG islands in their promoters which can be found as hypermethylated in CC 
(Mikheev et al., 2004; Chung et al., 2009a; Chung et al., 2009b; Lee et al., 2009; Okino et al., 
2003; Lee et al., 2010; Song et al., 2009). Therefore, it is probable that inactivation of these 
genes by promoter hypermethylation induce activation of Wnt canonical pathway during 
cervical carcinogenesis. 
On the other hand, respecting the upstream activation of Wnt/β-catenin pathway, the over-
expression of pathway activators such as Wnt ligands, frizzled receptors, and disheveled 
has been described. There is evidence showing over-expression of WNT10B, -14, FZD10, and 
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DVL-1 in cervical cell lines (Kirikoshi & Katoh, 2002; Kirikoshi et al., 2001; Koike et al., 1999; 
Okino et al., 2003); nonetheless, this has not been explored in pathological specimens. 
 
Fig. 4. NKD and DVL are over-expressed from early staged lesions.  
Levels of Wnt regulators were assessed in cervical epithelial lesions by means of Immune-
histochemistry. Unexpectedly NKD1 and 2 were over-expressed showing an aberrant 
nuclear staining. As expected, DVL is over-expressed in cervical lesions. 
We have reported by genome-wide expression analysis in HPV16 CC tissues that one of the 
most altered pathways is Wnt/β-catenin. In our study, we observed a significant increment 
of Wnt4, -8a, Fzd2, GSK3β, and β-catenin in tumours. In addition, genes also belonging to 
this pathway are actively expressed in normal cervical epithelia, such as sFRP4, PPP2C, and 
FZD7 (Pérez-Plasencia et al., 2007). This evidence demonstrates two important facts: first, 
the deregulation in specific genes belonging to Wnt/β-catenin pathway could play an 
important role in cervical carcinogenesis, and second, the presence of some Wnt/β-catenin-
related genes in normal tissues suggests that this pathway is involved in cervical epithelial 
differentiation. Interestingly, gene components of the planar cell polarity (PCP) pathway 
were actively expressed in normal cervices, indicating that this branch of Wnt signaling is 
down regulated in CC. In vertebrates, PCP is considered as any process affecting cell 
polarity within an epithelial plane and involving one or more core PCP genes. PCP has 
shown to be an important developmental and adult tissue differentiation process (Wang & 
Nathans, 2007). To our knowledge, there are no previous reports showing active PCP genes 
in normal cervical epithelia. This result demonstrates that during the carcinogenesis process, 
infected cervical cells turn off the PCP pathway, activating the canonical pathway with a 
concurrent increase of genes participating in it, for instance, Wnt4, -8A, FZD2, CTNNB1, 
among others. The activation of the canonical pathway leads to the upregulation of target 
genes such as MYC, JUN, FOS, and RRAS, which are related to growth promotion (Pérez-
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Plasencia et al., 2007). Notwithstanding, NKD1 and NKD2 expression in CC specimens 
show an increased expression and aberrant nuclear localization as an early event, occurring 
from low grade squamous intraepithelial lesions to carcinoma (Figure 4). Apparently, the 
aberrant localization is due to a lack of 300 bp in transcripts sequence (Pérez-Plasencia 
unpublished results), indicating a key role of NKD genes in Wnt pathway regulation on CC 
tumour progression.  
Additionaly, some experiments in vitro have shown that high-risk HPV16 E6 oncoprotein 
was capable of activate Wnt/beta-catenin pathway in an E6AP dependent fashion (Lichtig et 
al., 2010). Altogether, these data are in concordance with the fact that human genital 
keratinocytes immortalized with high-risk HPV need the activation of Wnt canonical 
pathway to be transformed and suggest that this event is essential in the cervical 
tumourigenesis (Uren et al., 2005). 
4. Conclusions 
The extensive use of the Papanicolau smear and colposcopy examination have significantly 
decreased the CC mortality rates; however, this neoplasm still remains as the second cause 
of death in women worldwide. Concordantly, HPV presence has been found in more than 
99% of CC, hence HPV infection is considered as the most important etiologic factor in 
cervical carcinogenesis. Even though HPV infection is very common among the young 
sexually active population, only a small fraction of infected individuals develop cervical 
carcinoma later in life. Thus, HPV is considered only as an initial hit in the multistep 
carcinogenesis that leads to the development of CC. The molecular pathways involved in 
the progression of HPV-infected cells to CC have not been accurately identified. Here, we 
reviewed the role of Wnt/β-catenin pathway over-activation and the inactivation of planar 
cell polarity pathway in CC cells as a second hit to develop CC; moreover, one key regulator 
of PCP, NKD, is aberrantly localized in nucleus and overexpressed in CC. In this regard, 
many reports have described that Wnt/β-catenin pathway is aberrantly active in CC, where 
common tumour-causing mutations on the genes of this pathway, such as APC, Axin and 
CTNNB1 have not been found. Thus Wnt/β-catenin pathway over-activation could be 
caused by disregulation in upstream modulators, by means of negative regulators 
inactivation or over-expression of activators. On the other hand, an additional branch in 
Wnt signaling pathway, that could be determinant during CC pathogenesis, is the planar 
cell polarity (PCP) pathway, which is involved in cellular differentiation. PCP is a key via in 
differentiation and the morphogenetic process involved in development of epithelia. In 
normal cervical epithelia, cells are polarized and migrate from basal to the luminal space as 
they differentiate. Interestingly, PCP component genes are repressed in CC, indicating that 
this pathway could be abated prior the establishment of the neoplasia. From the diagnostic 
point of view, this fact could be of great importance because the possibility to reveal PCP 
downregulation as an early tumourigenic process could provide for potential methods of 
early molecular markers detection in patients who have HPV and will develop CC. 
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